← FDA Drug Approvals (Drugs@FDA)

KLISYRI

NDA · New Drug Application · Sponsor: ALMIRALL · Approved 2020-12-14

Drug application

FDA Application #

NDA213189

Application type

New Drug Application

Brand name

KLISYRI

Generic name

TIRBANIBULIN

Active ingredients

TIRBANIBULIN

Dosage form

OINTMENT

Route

TOPICAL

Marketing status

Prescription

Sponsor

ALMIRALL

Manufacturer

Almirall, LLC

First approval

2020-12-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown